Approvals/TGA/HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection 5 mL vial

Approved

STANDARD

HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection 5 mL vial

CSL Behring (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 4ced38fe47e6aebf
Product Name: HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection 5 mL vial
Artg Id: 207386
Artg Name: HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection 5 mL vial
Sponsor: CSL Behring (Australia) Pty Ltd
Company Detail Path: /organization/csl-behring-australia-pty-ltd
Artg Date: 2014-05-08
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/aa49f3646140819caba76b032b2b004a.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/a0a042b29b97fb74014f312f762160f3.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

4ced38fe47e6aebf

Type

Standard